Sandhu, Harbinder K; Booth, Katie; Furlan, Andrea D; Shaw, Jane; Carnes, Dawn; Taylor, Stephanie JC; Abraham, Charles; ... Underwood, Martin; + view all Sandhu, Harbinder K; Booth, Katie; Furlan, Andrea D; Shaw, Jane; Carnes, Dawn; Taylor, Stephanie JC; Abraham, Charles; Alleyne, Sharisse; Balasubramanian, Shyam; Betteley, Lauren; Haywood, Kirstie L; Iglesias-Urrutia, Cynthia P; Krishnan, Sheeja; Lall, Ranjit; Manca, Andrea; Mistry, Dipesh; Newton, Sian; Noyes, Jennifer; Nichols, Vivien; Padfield, Emma; Rahman, Anisur; Seers, Kate; Tang, Nicole KY; Tysall, Colin; Eldabe, Sam; Underwood, Martin; - view fewer (2023) Reducing Opioid Use for Chronic Pain With a Group-Based Intervention: A Randomized Clinical Trial. JAMA , 329 (20) pp. 1745-1756. 10.1001/jama.2023.6454.

Preview	Text (Article) Rahman_Reducing Opioid Use for Chronic Pain With a Group-Based Intervention_AAM.pdf Download (537kB) | Preview
Preview	Text (Figure 1) Sandhu H Figure 1_ Updated version 16.02.23 (1).pdf - Accepted Version Download (251kB) | Preview
Preview	Text (Figure 2) Sandhu H Figure 2_Updated version 17.02.23.pdf - Accepted Version Download (304kB) | Preview
Preview	Text (Supplement 1) Rahman_Sandhu H I-WOTCH Supplment 1 Accepted docs.pdf Download (877kB) | Preview
Preview	Text (Supplement 2) Rahman_Sandhu H I-WOTCH Supplement 2 file Accepted.pdf Download (936kB) | Preview

Abstract

IMPORTANCE: Opioid use for chronic nonmalignant pain can be harmful. OBJECTIVE: To test whether a multicomponent, group-based, self-management intervention reduced opioid use and improved pain-related disability compared with usual care. DESIGN, SETTING, AND PARTICIPANTS: Multicentered, randomized clinical trial of 608 adults taking strong opioids (buprenorphine, dipipanone, morphine, diamorphine, fentanyl, hydromorphone, methadone, oxycodone, papaveretum, pentazocine, pethidine, tapentadol, and tramadol) to treat chronic nonmalignant pain. The study was conducted in 191 primary care centers in England between May 17, 2017, and January 30, 2019. Final follow-up occurred March 18, 2020. INTERVENTION: Participants were randomized 1:1 to either usual care or 3-day-long group sessions that emphasized skill-based learning and education, supplemented by 1-on-1 support delivered by a nurse and lay person for 12 months. MAIN OUTCOMES AND MEASURES: The 2 primary outcomes were Patient-Reported Outcomes Measurement Information System Pain Interference Short Form 8a (PROMIS-PI-SF-8a) score (T-score range, 40.7-77; 77 indicates worst pain interference; minimal clinically important difference, 3.5) and the proportion of participants who discontinued opioids at 12 months, measured by self-report. RESULTS: Of 608 participants randomized (mean age, 61 years; 362 female [60%]; median daily morphine equivalent dose, 46 mg [IQR, 25 to 79]), 440 (72%) completed 12-month follow-up. There was no statistically significant difference in PROMIS-PI-SF-8a scores between the 2 groups at 12-month follow-up (-4.1 in the intervention and -3.17 in the usual care groups; between-group difference: mean difference, -0.52 [95% CI, -1.94 to 0.89]; P = .15). At 12 months, opioid discontinuation occurred in 65 of 225 participants (29%) in the intervention group and 15 of 208 participants (7%) in the usual care group (odds ratio, 5.55 [95% CI, 2.80 to 10.99]; absolute difference, 21.7% [95% CI, 14.8% to 28.6%]; P < .001). Serious adverse events occurred in 8% (25/305) of the participants in the intervention group and 5% (16/303) of the participants in the usual care group. The most common serious adverse events were gastrointestinal (2% in the intervention group and 0% in the usual care group) and locomotor/musculoskeletal (2% in the intervention group and 1% in the usual care group). Four people (1%) in the intervention group received additional medical care for possible or probable symptoms of opioid withdrawal (shortness of breath, hot flushes, fever and pain, small intestinal bleed, and an overdose suicide attempt). CONCLUSIONS AND RELEVANCE: In people with chronic pain due to nonmalignant causes, compared with usual care, a group-based educational intervention that included group and individual support and skill-based learning significantly reduced patient-reported use of opioids, but had no effect on perceived pain interference with daily life activities. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN49470934.

Download activity - last month

Export as JSONCSVXML

Download activity - last 12 months

Export as CSVXMLJSON

Downloads by country - last 12 months

Export as JSONCSVXML

Archive Staff Only

View Item